CRIS Current Research Information System

Introduction: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice. Method: In a naturalistic national cohort of 449 patients who initiated LAI treatment in the STAR Network Depot Study, two groups were identified based on off– or on–label prescriptions. A multivariate logistic regression analysis was used to test several clinically relevant variables and identify those associated with the choice of FGA vs SGA prescription in the off–label group. Results: SGA LAIs were more commonly prescribed in everyday practice, without significant differences in their on– and off–label use. Approximately 1 in 4 patients received an off–label prescription. In the off–label group, the most frequent diagnoses were bipolar disorder (67.5%) or any personality disorder (23.7%). FGA vs SGA LAI choice was significantly associated with BPRS thought disorder (OR = 1.22, CI95% 1.04 to 1.43, p = 0.015) and hostility/suspiciousness (OR = 0.83, CI95% 0.71 to 0.97, p = 0.017) dimensions. The likelihood of receiving an SGA LAI grew steadily with the increase of the BPRS thought disturbance score. Conversely, a preference towards prescribing an FGA was observed with higher scores at the BPRS hostility/suspiciousness subscale. Conclusion: Our study is the first to identify predictors of FGA vs SGA choice in patients treated with off–label LAI antipsychotics. Demographic characteristics, i.e. age, sex, and substance/alcohol use co–morbidities did not appear to influence the choice towards FGAs or SGAs. Despite a lack of evidence, clinicians tend to favour FGA over SGA LAIs in bipolar or personality disorder patients with relevant hostility. Further research is needed to evaluate treatment adherence and clinical effectiveness of these prescriptive patterns.

Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study / D'Agostino A.; Aguglia A.; Barbui C.; Bartoli F.; Carra G.; Cavallotti S.; Chirico M.; Ostinelli E.G.; Zangani C.; Martinotti G.; Ostuzzi G.; Nose M.; Purgato M.; Turrini G.; Mazzi M.A.; Papola D.; Gastaldon C.; Terlizzi S.; Bertolini F.; Piccoli A.; Ruggeri M.; De Fazio P.; Magliocco F.; Caroleo M.; Raffaele G.; Ostinelli E.G.; Bergamelli E.; Lucii C.; Bolognesi S.; Debolini S.; Pierantozzi E.; Fargnoli F.; Del Zanna M.; Giannini A.; Luccarelli L.; De Capua A.; Annese P.M.; Cerretini M.; Tozzi F.; Magnani N.; Cardamone G.; Bardicchia F.; Facchi E.; Soscia F.; Zotos S.; Biancosino B.; Zonta F.; Pompei F.; Callegari C.; Zizolfi D.; Poloni N.; Ielmini M.; Caselli I.; Giana E.; Buzzi A.; Diurni M.; Milano A.; Sani E.; Calzolari R.; Bortolaso P.; Piccinelli M.; Cazzamalli S.; Alberini G.; Piantanida S.; Costantini C.; Paronelli C.; Di Caro A.; Moretti V.; Gozzi M.; D'Ippolito C.; Barbanti S.V.; Alessandro P.; Corbo M.; Campese O.; Fiori F.; Lorusso M.; Di Capro L.; Viceconte D.; Mancini V.; Suraniti F.; Signorelli M.S.; Rossi E.; Lupoli P.; Menchetti M.; Terzi L.; Boso M.; Risaro P.; De Paoli G.; Catania C.; Tarricone I.; Caretto V.; Storbini V.; Emiliani R.; Balzarro B.; Tabacchi T.; Nava R.; Bono A.; Provenzi M.; Brambilla G.; Aspesi F.; Trotta G.; Tremolada M.; Castagna G.; Bava M.; Verrengia E.; Lucchi S.; Oriani M.G.; Barchiesi M.; Pacetti M.; Amerio A.; Amore M.; Serafini G.; Magni L.R.; Rossi G.; Beneduce R.; Tura G.B.; Laffranchini L.; Mastromo D.; Ferrato F.; Restaino F.; Monzani E.; Porcellana M.; Limosani I.; Ghio L.; Ferro M.; Parise V.F.; Balletta G.; Addeo L.; De Vivo E.; Di Benedetto R.; Pinna F.; Carpiniello B.; Spano M.; Giacomin M.; Pecile D.; Mattei C.; Fabrici E.P.; Panarello S.; Peresson G.; Vitucci C.; Bonavigo T.; Perini G.; Boschello F.; Strizzolo S.; Gardellin F.; di Giannantonio M.; Moretti D.; Fizzotti C.; Cossetta E.; Di Gregorio L.; Sozzi F.; Boncompagni G.; La Barbera D.; Colli G.; Laurenzi S.; Calandra C.; Luca M.. - In: BMC PSYCHIATRY. - ISSN 1471-244X. - ELETTRONICO. - 22:1(2022), pp. 442.1-442.9. [10.1186/s12888-022-04071-2]

Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study

Lupoli P.;Menchetti M.;Terzi L.;Tarricone I.;Caretto V.;Storbini V.;Emiliani R.;Balzarro B.;
2022

Abstract

Introduction: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice. Method: In a naturalistic national cohort of 449 patients who initiated LAI treatment in the STAR Network Depot Study, two groups were identified based on off– or on–label prescriptions. A multivariate logistic regression analysis was used to test several clinically relevant variables and identify those associated with the choice of FGA vs SGA prescription in the off–label group. Results: SGA LAIs were more commonly prescribed in everyday practice, without significant differences in their on– and off–label use. Approximately 1 in 4 patients received an off–label prescription. In the off–label group, the most frequent diagnoses were bipolar disorder (67.5%) or any personality disorder (23.7%). FGA vs SGA LAI choice was significantly associated with BPRS thought disorder (OR = 1.22, CI95% 1.04 to 1.43, p = 0.015) and hostility/suspiciousness (OR = 0.83, CI95% 0.71 to 0.97, p = 0.017) dimensions. The likelihood of receiving an SGA LAI grew steadily with the increase of the BPRS thought disturbance score. Conversely, a preference towards prescribing an FGA was observed with higher scores at the BPRS hostility/suspiciousness subscale. Conclusion: Our study is the first to identify predictors of FGA vs SGA choice in patients treated with off–label LAI antipsychotics. Demographic characteristics, i.e. age, sex, and substance/alcohol use co–morbidities did not appear to influence the choice towards FGAs or SGAs. Despite a lack of evidence, clinicians tend to favour FGA over SGA LAIs in bipolar or personality disorder patients with relevant hostility. Further research is needed to evaluate treatment adherence and clinical effectiveness of these prescriptive patterns.
2022
BMC PSYCHIATRY
Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study / D'Agostino A.; Aguglia A.; Barbui C.; Bartoli F.; Carra G.; Cavallotti S.; Chirico M.; Ostinelli E.G.; Zangani C.; Martinotti G.; Ostuzzi G.; Nose M.; Purgato M.; Turrini G.; Mazzi M.A.; Papola D.; Gastaldon C.; Terlizzi S.; Bertolini F.; Piccoli A.; Ruggeri M.; De Fazio P.; Magliocco F.; Caroleo M.; Raffaele G.; Ostinelli E.G.; Bergamelli E.; Lucii C.; Bolognesi S.; Debolini S.; Pierantozzi E.; Fargnoli F.; Del Zanna M.; Giannini A.; Luccarelli L.; De Capua A.; Annese P.M.; Cerretini M.; Tozzi F.; Magnani N.; Cardamone G.; Bardicchia F.; Facchi E.; Soscia F.; Zotos S.; Biancosino B.; Zonta F.; Pompei F.; Callegari C.; Zizolfi D.; Poloni N.; Ielmini M.; Caselli I.; Giana E.; Buzzi A.; Diurni M.; Milano A.; Sani E.; Calzolari R.; Bortolaso P.; Piccinelli M.; Cazzamalli S.; Alberini G.; Piantanida S.; Costantini C.; Paronelli C.; Di Caro A.; Moretti V.; Gozzi M.; D'Ippolito C.; Barbanti S.V.; Alessandro P.; Corbo M.; Campese O.; Fiori F.; Lorusso M.; Di Capro L.; Viceconte D.; Mancini V.; Suraniti F.; Signorelli M.S.; Rossi E.; Lupoli P.; Menchetti M.; Terzi L.; Boso M.; Risaro P.; De Paoli G.; Catania C.; Tarricone I.; Caretto V.; Storbini V.; Emiliani R.; Balzarro B.; Tabacchi T.; Nava R.; Bono A.; Provenzi M.; Brambilla G.; Aspesi F.; Trotta G.; Tremolada M.; Castagna G.; Bava M.; Verrengia E.; Lucchi S.; Oriani M.G.; Barchiesi M.; Pacetti M.; Amerio A.; Amore M.; Serafini G.; Magni L.R.; Rossi G.; Beneduce R.; Tura G.B.; Laffranchini L.; Mastromo D.; Ferrato F.; Restaino F.; Monzani E.; Porcellana M.; Limosani I.; Ghio L.; Ferro M.; Parise V.F.; Balletta G.; Addeo L.; De Vivo E.; Di Benedetto R.; Pinna F.; Carpiniello B.; Spano M.; Giacomin M.; Pecile D.; Mattei C.; Fabrici E.P.; Panarello S.; Peresson G.; Vitucci C.; Bonavigo T.; Perini G.; Boschello F.; Strizzolo S.; Gardellin F.; di Giannantonio M.; Moretti D.; Fizzotti C.; Cossetta E.; Di Gregorio L.; Sozzi F.; Boncompagni G.; La Barbera D.; Colli G.; Laurenzi S.; Calandra C.; Luca M.. - In: BMC PSYCHIATRY. - ISSN 1471-244X. - ELETTRONICO. - 22:1(2022), pp. 442.1-442.9. [10.1186/s12888-022-04071-2]
D'Agostino A.; Aguglia A.; Barbui C.; Bartoli F.; Carra G.; Cavallotti S.; Chirico M.; Ostinelli E.G.; Zangani C.; Martinotti G.; Ostuzzi G.; Nose M.; Purgato M.; Turrini G.; Mazzi M.A.; Papola D.; Gastaldon C.; Terlizzi S.; Bertolini F.; Piccoli A.; Ruggeri M.; De Fazio P.; Magliocco F.; Caroleo M.; Raffaele G.; Ostinelli E.G.; Bergamelli E.; Lucii C.; Bolognesi S.; Debolini S.; Pierantozzi E.; Fargnoli F.; Del Zanna M.; Giannini A.; Luccarelli L.; De Capua A.; Annese P.M.; Cerretini M.; Tozzi F.; Magnani N.; Cardamone G.; Bardicchia F.; Facchi E.; Soscia F.; Zotos S.; Biancosino B.; Zonta F.; Pompei F.; Callegari C.; Zizolfi D.; Poloni N.; Ielmini M.; Caselli I.; Giana E.; Buzzi A.; Diurni M.; Milano A.; Sani E.; Calzolari R.; Bortolaso P.; Piccinelli M.; Cazzamalli S.; Alberini G.; Piantanida S.; Costantini C.; Paronelli C.; Di Caro A.; Moretti V.; Gozzi M.; D'Ippolito C.; Barbanti S.V.; Alessandro P.; Corbo M.; Campese O.; Fiori F.; Lorusso M.; Di Capro L.; Viceconte D.; Mancini V.; Suraniti F.; Signorelli M.S.; Rossi E.; Lupoli P.; Menchetti M.; Terzi L.; Boso M.; Risaro P.; De Paoli G.; Catania C.; Tarricone I.; Caretto V.; Storbini V.; Emiliani R.; Balzarro B.; Tabacchi T.; Nava R.; Bono A.; Provenzi M.; Brambilla G.; Aspesi F.; Trotta G.; Tremolada M.; Castagna G.; Bava M.; Verrengia E.; Lucchi S.; Oriani M.G.; Barchiesi M.; Pacetti M.; Amerio A.; Amore M.; Serafini G.; Magni L.R.; Rossi G.; Beneduce R.; Tura G.B.; Laffranchini L.; Mastromo D.; Ferrato F.; Restaino F.; Monzani E.; Porcellana M.; Limosani I.; Ghio L.; Ferro M.; Parise V.F.; Balletta G.; Addeo L.; De Vivo E.; Di Benedetto R.; Pinna F.; Carpiniello B.; Spano M.; Giacomin M.; Pecile D.; Mattei C.; Fabrici E.P.; Panarello S.; Peresson G.; Vitucci C.; Bonavigo T.; Perini G.; Boschello F.; Strizzolo S.; Gardellin F.; di Giannantonio M.; Moretti D.; Fizzotti C.; Cossetta E.; Di Gregorio L.; Sozzi F.; Boncompagni G.; La Barbera D.; Colli G.; Laurenzi S.; Calandra C.; Luca M.
1.01 Articolo in rivista
File in questo prodotto:
File Dimensione Formato  
s12888-022-04071-2.pdf

accesso aperto

Descrizione: D'Agostino_BMC Psychiatry 2022
Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.04 MB
Formato Adobe PDF
Visualizza/Apri
1.04 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/919778
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact